e.g. Tata motors, Reliance MF, 500570

Kilitch Drugs(I) Ltd. - Research Center

524500 KILITCH Group (T) BSE data
 
Back to Company Page
Statement:

Profit loss account

(Rs crore)
Mar ' 26 Mar ' 25 Mar ' 24 Mar ' 23 Mar ' 22
Income
Operating income 188.57 181.59 131.60 117.78 105.16
Expenses
Material consumed 90.92 93.59 67.72 60.87 62.36
Manufacturing expenses 2.48 2.61 2.36 2.06 2.00
Personnel expenses 12.34 10.03 7.91 7.47 6.15
Selling expenses 0.52 1.87 0.06 0.09 0.02
Adminstrative expenses 49.88 42.65 33.22 30.13 23.63
Expenses capitalised - - - - -
Cost of sales 156.14 150.75 111.28 100.61 94.16
Operating profit 32.44 30.84 20.32 17.17 11.00
Other recurring income 13.85 13.72 6.19 4.60 4.56
Adjusted PBDIT 46.28 44.55 26.51 21.77 15.56
Financial expenses 2.44 2.13 1.91 0.99 0.66
Depreciation 2.29 1.74 1.24 1.34 0.96
Other write offs - - - - -
Adjusted PBT 41.55 40.69 23.35 19.45 13.93
Tax charges 9.15 9.53 5.78 3.73 3.40
Adjusted PAT 32.40 31.16 17.57 15.72 10.53
Non recurring items - - - - -
Other non cash adjustments - - - - -
Reported net profit 32.40 31.16 17.57 15.72 10.53
Earnigs before appropriation 195.09 162.69 131.53 113.96 98.24
Equity dividend - - - - -
Preference dividend - - - - -
Dividend tax - - - - -
Retained earnings 195.09 162.69 131.53 113.96 98.24
Close
Add Kilitch Drugs(I) Ltd. to your Portfolio
 
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Kilitch Drugs(I) Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback